Researchers present preliminary findings of Alzheimer's disease onset and progression in Mexican Americans and other diverse, often overlooked populations.
Transplanting ACE2-mesenchymal stem cells shows promise for the treatment of COVID-19. A small study reveals seven severely ill patients who received the stem cell transplant recovered and were discharged from hospital within 14 days.
